| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |